Now showing items 1-3 of 3
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
(BioMed Central, 2014-05-15)
Background: Alteplase is the only approved thrombolytic agent for acute ischaemic stroke. The overall benefit from alteplase is substantial, but some evidence indicates that alteplase also has negative effects on the ...
Progressive striatal necrosis associated with anti-NMDA receptor antibodies
(BioMed Central, 2013-05-31)
Background: We report a case of childhood onset, generalized dystonia due to slowly progressive bilateral striatal necrosis associated with anti-N-methyl-D-aspartate receptor (NMDAR) antibodies. This clinical phenotype ...
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design
(BioMed Central, 2013-07-17)
Background: Ischemic stroke in young adults is a major health problem being associated with a higher vascular morbidity and mortality compared to controls, and a stroke recurrence rate of 25% during the first decade. ...